The DOI matches its Crossref record; 410 of the 410 references it cites were found in a registry or an index.
The role of SOX family members in solid tumours and metastasis
Open accessAbstract
Cancer is a heavy burden for humans across the world with high morbidity and mortality. Transcription factors including sex determining region Y (SRY)-related high-mobility group (HMG) box (SOX) proteins are thought to be involved in the regulation of specific biological processes. The deregulation of gene expression programs can lead to cancer development. Here, we review the role of the SOX family in breast cancer, prostate cancer, renal cell carcinoma, thyroid cancer, brain tumours, gastrointestinal and lung tumours as well as the entailing therapeutic implications. The SOX family consists of more than 20 members that mediate DNA binding by the HMG domain and have regulatory functions in development, cell-fate decision, and differentiation. SOX2, SOX4, SOX5, SOX8, SOX9, and SOX18 are up-regulated in different cancer types and have been found to be associated with poor prognosis, while the up-regulation of SOX11 and SOX30 appears to be favourable for the outcome in other cancer types. SOX2, SOX4, SOX5 and other SOX members are involved in tumorigenesis, e.g. SOX2 is markedly up-regulated in chemotherapy resistant cells. The SoxF family (SOX7, SOX17, SOX18) plays an important role in angio- and lymphangiogenesis, with SOX18 seemingly being an attractive target for anti-angiogenic therapy and the treatment of metastatic disease in cancer. In summary, SOX transcription factors play an important role in cancer progression, including tumorigenesis, changes in the tumour microenvironment, and metastasis. Certain SOX proteins are potential molecular markers for cancer prognosis and putative potential therapeutic targets, but further investigations are required to understand their physiological functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 401–410 of 410
Interleukin-6 upregulates SOX18 expression in osteosarcoma
Wu, Z., Yang, W., Liu, J., & Zhang, F. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s149905 · Cited by 12
Generation and characterization of a novel, permanently active S100P mutant
Austermann, J., Nazmi, A. R., Heil, A., Fritz, G., Koliński, M., Filipek, S., & Gerke, V. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.012 · Cited by 11
Feng, Y., Xiao, F., Yang, N., Zhu, N., Fu, Y., Zhang, H., & Yang, G.-S. (2017) · PubMed Central · Cited by 11
A Model for Dimerization of the SOX Group E Transcription Factor Family
Ramsook, S. N., Ni, J., Shahangian, S., Vakiloroayaei, A., Khan, N. P., Kwan, J. J., & Donaldson, L. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161432 · Cited by 10
Zhang, S., Liu, J., Xu, K., & Li, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7551 · Cited by 10
Thimsen, V., John, N., Buchfelder, M., Flitsch, J., Fahlbusch, R., Stefanits, H., Knosp, E., Losa, M., Buslei, R., & Hölsken, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15977-3 · Cited by 8
SOX2: A Glioma‐Specific Marker and a Potential Target for Therapy
Eschbacher, J. M., Yeh, R., Smirnov, I., Feuerstein, B. G., & Coons, S. W. (2008) · The FASEB Journal · doi:10.1096/fasebj.22.1_supplement.706.18 · Cited by 5
Mouse Models to Study Leptin in Breast Cancer Stem Cells
Thiagarajan, P. S., & Reizes, O. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_7 · Cited by 2
Tumorigenesis of Glioma-Initiating Cells: Role of Sox11
Kondo, T. (2011) · Springer eBooks · doi:10.1007/978-94-007-1709-1_11 · Cited by 1
Zhou, L., & Kang, M. (2017) · PubMed Central · Cited by 1
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
Simeonov, K. P., Byrns, C. N., Clark, M. L., Norgard, R. J., Martin, B., Stanger, B. Z., Shendure, J., McKenna, A., & Lengner, C. J. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.005 · Cited by 385
Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
Reticker-Flynn, N. E., Zhang, W., Belk, J. A., Basto, P. A., Escalante, N. K., Pilarowski, G. O. W., Bejnood, A., Martins, M. M., Kenkel, J. A., Linde, I. L., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.019 · Cited by 385
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis
Guccini, I., Revandkar, A., D'Ambrosio, M., Colucci, M., Pasquini, E., Mosole, S., Troiani, M., Brina, D., Sheibani-Tezerji, R., Elia, A. R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.10.012 · Cited by 185
Sox13 promotes hepatocellular carcinoma metastasis by transcriptionally activating Twist1
Feng, M., Fang, F., Fang, T., Jiao, H., You, S., Wang, X., & Zhao, W. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0445-0 · Cited by 25
Metadata
- Authors
- Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 67
- Issue
- Pt 1
- Pages
- 122-153
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2925334213
- Cited by
- 487
- References
- 410
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.